The merger will create the worlds largest pharmaceutical company, but it depends on the progress in clinical trials of a potential blockbuster anti-cancer drug. Behind the scenes a powerful syndicate attempts to manipulate events for personal gain.
Individuals get caught up in the relentless process. Relationships crack, while others strengthen. The least fortunate pay with their lives.
About the author
ROBERT POTTER worked for thirty three years in Information Technology in large global pharmaceutical companies. He successfully navigated several corporate mergers, experiencing at first hand their impact on employees at all levels. He saw their huge costs, measured in both dollars and jobs, and their benefits, which invariably fell short of the stated goals. On the plus side none of his colleagues died in suspicious circumstances. Now retired, he lives with his wife in SE Pennsylvania, playing golf, tennis and writing. He has two children, both working but neither in the pharmaceutical business.